# Improved Survival with Bevacizumab in Advanced Cervical Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/improved-survival-with-bevacizumab-in-advanced-cervical-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Krishnansu S. Tewari,Michael W. Sill,Harry J. Long,Richard T. Penson,Helen Huang,Lois M. Ramondetta,Lisa M. Landrum,Ana Oaknin,Thomas Reid,Mario M. Leitão,Helen E. Michael,Bradley J. Monk |
| Citations | 1,512 |
| DOI | 10.1056/nejmoa1309748 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1309748?articleTools=true |
| OpenAlex ID | https://openalex.org/W2100756525 |
| PMID | 24552320 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Bradley J. Monk](https://scholariq.org/researchers/bradley-j-monk/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)

## Paper topics

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.